Investor · Warsaw, R9

Neil Milne

Open Neil in the network graph →

Filings

7

SEC Form D

Connections

58

co-filers

Capital

$351.0M

across filings

Active

Dec 2015

to Jan 2019

Most-connected co-filers (58)

Stephen Richmond · Warsaw, R97 shared George Swirski · Warsaw, R95 shared Pawel Gierynski · Warsaw, R95 shared Brenda Smith · Conshohocken, PA3 shared George P. Vlasuk · Cambridge, MA3 shared Alan Crane · MEDFORD, MA3 shared Rick P. Lundberg · Cambridge, MA3 shared Aaron Katz · New York, NY3 shared Jonathan Neiss · NEW YORK, NY3 shared David P. Madden · Cambridge, MA3 shared Donald E. Conrad · Islandia, NY3 shared Vinzenz P. Ploerer · Cambridge, MA3 shared David Icikson · New York, NY3 shared Seth Lax · NEW YORK, NY3 shared William Manby · Akron, OH3 shared Jeffrey D. Janus · Medford, MA2 shared Vincent R. Zurawski · Medford, MA2 shared John Creecy · Boulder, CO2 shared Charles V. Long · Oklahoma City, OK2 shared Rachael Classi · CHARLOTTE, NC2 shared John Ackerly · Grand Cayman, Cayman Islands2 shared Kevin Bitterman · Cambridge, MA2 shared Andrew G. Dodson · SAN FRANCISCO, CA2 shared John K. Mcgeehan · Medford, MA2 shared

Recent filings (7)

Navitor Pharmaceuticals, Inc.Jan 2019 · 29 co-filers$11.3M Navitor Pharmaceuticals, Inc.Mar 2018 · 27 co-filers$25.0M Abris CEE Mid-Market Fund III LPMay 2017 · 15 co-filers$382.0M Abris CEE Mid-Market Fund III LPMay 2016 · 15 co-filers$324.2M Ascendance Biotechnology, Inc.May 2016 · 18 co-filers$300K Navitor Pharmaceuticals, Inc.Dec 2015 · 25 co-filers$33.3M Ascendance Biotechnology, Inc.Dec 2015 · 8 co-filers$750K

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Neil in the interactive graph →